|
MechanismPDE4B inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismPDE4B inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Goldenrod Therapeutics
0 Patents (Medical) associated with Goldenrod Therapeutics
100 Deals associated with Goldenrod Therapeutics
100 Translational Medicine associated with Goldenrod Therapeutics